查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1543875

血管成形术用气球的全球市场

Angioplasty Balloons
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血管成形术用气球市场预计将达到 38 亿美元

2023年全球血管成形术用气球市场估计为29亿美元，预计2030年将达到38亿美元，2023-2030年分析期间复合年增长率为3.9%。普通气球是本报告分析的细分市场之一，预计复合年增长率为 3.9%，到分析期结束时将达到 21 亿美元。在分析期间，药物涂层球囊市场预计将以 4.1% 的复合年增长率成长。

美国市场预估达7.682亿美元，中国预计复合年增长率为5.9%

预计 2023 年美国血管成形术用气球市场规模将达 7.682 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达到7.876亿美元，2023年至2030年复合年增长率为5.9%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.6% 和 3.0%。在欧洲，德国的复合年增长率预计为 3.0%。

全球血管成形术用气球市场－主要趋势与驱动因素总结

血管成形术用气球如何彻底改变心臟照护？

血管成形术用气球是介入性心臟病学领域的重要工具，在冠状动脉疾病（CAD）的治疗中发挥至关重要的作用。这些装置用于经皮冠状动脉介入治疗（PCI），以扩宽狭窄或阻塞的冠状动脉，恢復心肌的血流，并缓解胸痛和呼吸短促等症状。在此过程中，将末端带有放气球的导管插入受影响的动脉中。一旦就位，气球就会膨胀，将斑块推向动脉壁并扩张血管。血管成形术用气球的引入彻底改变了心臟护理，为冠状动脉绕道手术移植术 (CABG) 提供了微创替代方案，减少了患者的康復时间和住院时间。

哪些技术创新提高了血管成形术用气球的有效性？

技术的进步大大提高了血管成形术用气球的有效性和安全性。药物释放型球囊 (DEB) 的开发透过将机械斑块压缩与局部药物输送相结合，代表了预防血管再阻塞或动脉血管再阻塞的重大创新。这些球囊涂有抗增生药物，当膨胀时，这些药物会释放到动脉壁中，以抑制导致血管再阻塞的疤痕组织的生长。此外，球囊导管的引入透过对斑块进行受控切割，改善了我们处理特别顽固或钙化病变的方式。这些进步不仅提高了血管成形术的成功率，而且减少了再次手术的需要并改善了患者的长期预后。

为什么以病人为中心的照护对于血管成形术用气球的引入至关重要？

以患者为中心的照护是采用血管成形球囊手术并取得成功的重要因素。随着对个人化医疗的重视，医疗保健提供者越来越注重根据患者的个别需求和状况量身定制治疗方案。这种方法需要仔细评估患者的特定因素，包括动脉闭塞的严重程度和位置、一般健康状况和併发症。增强的影像技术和诊断工具可以准确规划和执行血管成形术，确保最佳的球囊选择和放置。此外，病患教育和术后护理在改善治疗结果方面发挥着重要作用。因为知情的患者更有可能遵循保持动脉健康所必需的处方药物和生活方式改变。在心臟护理中转向以患者为中心的整体方法不仅可以改善临床结果，还可以提高患者满意度和生活品质。

血管成形术用气球市场成长的因素有哪些？

血管成形术用气球市场的成长是由与技术进步、最终用途和不断发展的医疗保健实践相关的几个因素所推动的。由于人口老化和生活方式相关危险因素，全球冠心病负担持续增加，心血管疾病（特别是冠状动脉疾病）盛行率不断上升，已成为主要驱动因素。药物释放型球囊和切割/球囊导管等创新透过提高手术效率和患者治疗效果来推动市场成长。在基于导管的技术和诊断成像的进步的支持下，向微创治疗的转变正在扩大血管成形术用气球在不同患者群体中的使用。此外，随着对预防性护理和早期诊断的日益重视，血管成形术经常作为 CAD 的第一线治疗方法。新兴市场不断扩大的医疗基础设施和不断上涨的医疗成本也促进了市场成长，增加了先进心臟治疗技术的取得机会。此外，对个人化医疗和以患者为中心的护理模式的关注正在推动对客製化血管成形术解决方案的需求，进一步加速市场扩张。

受访企业范例（44家知名企业）

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endocor GmbH
  • Medtronic PLC
  • Terumo Corporation
  • The Spectranetics Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP10289

Global Angioplasty Balloons Market to Reach US$3.8 Billion by 2030

The global market for Angioplasty Balloons estimated at US$2.9 Billion in the year 2023, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 3.9% over the analysis period 2023-2030. Normal Balloons, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the Drug-Coated Balloons segment is estimated at 4.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$768.2 Million While China is Forecast to Grow at 5.9% CAGR

The Angioplasty Balloons market in the U.S. is estimated at US$768.2 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$787.6 Million by the year 2030 trailing a CAGR of 5.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 3.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Angioplasty Balloons Market - Key Trends and Drivers Summarized

How Are Angioplasty Balloons Revolutionizing Cardiac Care?

Angioplasty balloons are integral tools in the field of interventional cardiology, playing a pivotal role in the treatment of coronary artery disease (CAD). These devices are used in percutaneous coronary interventions (PCI) to dilate narrowed or blocked coronary arteries, restoring blood flow to the heart muscle and alleviating symptoms such as chest pain and shortness of breath. The procedure involves inserting a catheter with a deflated balloon at its tip into the affected artery. Once positioned, the balloon is inflated to compress the plaque against the artery walls, thereby widening the vessel. The advent of angioplasty balloons has revolutionized cardiac care by offering a minimally invasive alternative to coronary artery bypass grafting (CABG), reducing recovery times and hospital stays for patients.

What Technological Innovations Are Enhancing the Efficacy of Angioplasty Balloons?

Technological advancements have significantly enhanced the efficacy and safety of angioplasty balloons. The development of drug-eluting balloons (DEBs) represents a major innovation, combining mechanical plaque compression with localized drug delivery to prevent restenosis, or re-narrowing of the artery. These balloons are coated with antiproliferative drugs, which are released into the arterial wall during inflation, inhibiting the growth of scar tissue that can lead to restenosis. Additionally, the introduction of cutting and scoring balloons, equipped with tiny blades or scoring elements, provides an improved method for tackling particularly tough or calcified lesions by creating controlled incisions in the plaque. These advancements not only improve the success rates of angioplasty procedures but also reduce the need for repeat interventions, enhancing long-term patient outcomes.

Why Is Patient-Centric Care Vital in the Adoption of Angioplasty Balloons?

Patient-centric care is a critical factor in the adoption and success of angioplasty balloon procedures. With a growing emphasis on personalized medicine, healthcare providers are increasingly focusing on tailoring treatments to individual patient needs and conditions. This approach involves careful assessment of patient-specific factors such as the severity and location of arterial blockages, overall health, and coexisting medical conditions. Enhanced imaging techniques and diagnostic tools enable precise planning and execution of angioplasty procedures, ensuring optimal balloon selection and placement. Moreover, patient education and post-procedural care play a vital role in improving outcomes, as informed patients are more likely to adhere to prescribed medications and lifestyle modifications necessary to maintain artery health. The shift towards a holistic, patient-centric approach in cardiac care not only improves clinical outcomes but also enhances patient satisfaction and quality of life.

What Factors Are Driving Growth in the Angioplasty Balloons Market?

The growth in the angioplasty balloons market is driven by several factors related to technological advancements, end-use applications, and evolving healthcare practices. The increasing prevalence of cardiovascular diseases, particularly coronary artery disease, is a major driver, as the global burden of CAD continues to rise with aging populations and lifestyle-related risk factors. Technological innovations, such as drug-eluting balloons and cutting/scoring balloons, are propelling market growth by improving procedural efficacy and patient outcomes. The shift towards minimally invasive procedures, supported by advancements in catheter-based technologies and imaging modalities, is expanding the use of angioplasty balloons in diverse patient populations. Additionally, the growing emphasis on preventive healthcare and early diagnosis is leading to more frequent use of angioplasty as a first-line treatment for CAD. The expansion of healthcare infrastructure in emerging markets and increased healthcare expenditure are also contributing to market growth, providing greater access to advanced cardiac care technologies. Moreover, the focus on personalized medicine and patient-centric care models is driving demand for tailored angioplasty solutions, further accelerating market expansion.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Medical LLC
  • Endocor GmbH
  • Medtronic PLC
  • Terumo Corporation
  • The Spectranetics Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Angioplasty Balloons - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases Throws the Spotlight on Angioplasty Balloons
    • Technological Innovations in Drug-Eluting Balloons Propel Growth in the Market
    • Advances in Cutting and Scoring Balloons Expand Addressable Market Opportunity
    • Aging Population and Lifestyle-Related Risk Factors Drive Demand for Angioplasty Solutions
    • Minimally Invasive Procedures Trend Strengthens Business Case for Angioplasty Balloons
    • Integration of Advanced Imaging Techniques Generates Demand for Precision Angioplasty
    • Development of Portable and User-Friendly Devices Propels Adoption in Diverse Settings
    • Focus on Reducing Restenosis Rates Strengthens Business Case for Advanced Balloons
    • Integration of Digital Health and Remote Monitoring Generates New Market Opportunities
    • Trends in Outpatient Cardiac Care Propel Demand for Efficient Angioplasty Solutions
    • Investment in Innovative Catheter-Based Technologies Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Angioplasty Balloons Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Normal Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Normal Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Normal Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Drug-Coated Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Drug-Coated Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Drug-Coated Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Coronary Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Coronary Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Coronary Angioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Peripheral Angioplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Peripheral Angioplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • JAPAN
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • CHINA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • EUROPE
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Angioplasty Balloons by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • FRANCE
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • GERMANY
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Angioplasty Balloons by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • INDIA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Angioplasty Balloons by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Angioplasty Balloons by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030
  • AFRICA
    • Angioplasty Balloons Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Angioplasty Balloons by Product - Normal Balloons, Drug-Coated Balloons and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Angioplasty Balloons by Product - Percentage Breakdown of Value Sales for Normal Balloons, Drug-Coated Balloons and Other Products for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Angioplasty Balloons by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Angioplasty Balloons by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Angioplasty Balloons by Application - Coronary Angioplasty and Peripheral Angioplasty Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Angioplasty Balloons by Application - Percentage Breakdown of Value Sales for Coronary Angioplasty and Peripheral Angioplasty for the Years 2014, 2024 & 2030

IV. COMPETITION